Home ServicesProductTechnology
Company
AboutTeamNewsBlog Contact

News

2026 BIO Asia-Taiwan is Coming! Meet Us at Taipei Nangang Exhibition Center from 7/16–7/19

BloodScan Biotech invites you to witness the next step in precision medicine. The annual 2026 BIO Asia-Taiwan exhibition kicks off on July 1…

Read More →

BIO International Convention 2026! San Diego!

We are excited to showcase our breakthrough next-generation liquid biopsy solutions at BIO 2026 in San Diego! Visit us at the TAIWAN Pavilio…

Read More →

WHX Miami! World Health Expo

BloodScan Biotech is heading to World Health Expo (WHX) 2026! We will be showcasing our next-generation liquid biopsy solutions at WHX Miami…

Read More →

Advancing to Berkeley: BloodScan Selected for the 2026 Taiwan–Berkeley Health Innovation Accelerator (SPH)

BloodScan Selected for the 2026 Taiwan–Berkeley Health Innovation Accelerator, Strengthening Global Commercialization Strategy BloodScan is…

Read More →

Labyrinth One Leads CTC Technology, Debuting at AACR 2026

The BloodScan team will participate in one of the world's most prominent cancer research events, AACR Annual Meeting 2026 , from April 19-22…

Read More →

BloodScan Selected to Present at JPM Taipei 2026 Lightning Stage

BloodScan is honored to have been selected to present at the Lightning Stage of the J.P. Morgan Healthcare Conference Taipei 2026, where we…

Read More →

Capturing cancer cells from blood could help doctors choose the right breast cancer treatment

This story was originally published by Michigan Engineering News . Doctors may be able to spare patients unnecessarily aggressive breast can…

Read More →

Dr. Jui-Kun Shieh: A Champion of Holistic Cancer Care

In the memories of Dr. Jui-Kun Shieh, Chairman of the Taiwan Holistic Cancer Care Foundation, the starting point of his life was both ordina…

Read More →

BloodScan Named ADLM Top 6 Disruptive Technology Awardee

BloodScan is proud to have been recognized as a Top 6 finalist in the Disruptive Technology Award at the ADLM Annual Meeting, highlighting o…

Read More →

NBRP Incubates Over 60 Companies, Joins Forces with 7 Featured Enterprises to Target BioAsia - Global Bio & Investment

From July 24 to 27, the National Biotechnology Research Park (NBRP) adopted the theme of "Protecting Mountains" for its exhibition, bringing…

Read More →

NBRP Finalists Announced! Five Teams—CellMax Life, Oncocross, Bo-Shiun Chu’s Lab (Linkou Chang Gung), GeneReach, and Prophet Genomics—Stand Out – Global Bio & Investment

Today (the 22nd), the 2025 National Biotechnology Research Park (NBRP) Demo Day entered its second day. During the event, a startup pitch co…

Read More →

Eric Lin on Capturing Rare Cancer Cells for Early Detection and Treatment

Eric Lin, CEO of Bloodscan, shares how his team developed a new system to isolate live circulating tumor cells (CTCs) — without reagents or…

Read More →